Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs Memantine (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 18 Oct 2018 Status changed from recruiting to completed.
- 25 Nov 2014 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 06 Nov 2013 New trial record